Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,533 | 12,201 | 17,083 | 19,976 | N/A |
| Marketable Securities | 3,194 | 7,463 | 13,686 | 15,621 | N/A |
| Receivables | 7,744 | 6,066 | 10,138 | 11,656 | N/A |
| Inventories | 14,614 | 15,420 | 15,877 | 8,830 | N/A |
| TOTAL | $37,196 | $43,154 | $59,344 | $58,117 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 8,496 | 8,785 | 9,241 | 9,497 | N/A |
| Investments And Advances | 1,773 | 1,685 | 1,686 | 3,607 | 0 |
| Intangibles | 1,358 | 1,624 | 1,839 | 273 | 0 |
| Other Non-Current Assets | 2,448 | 2,763 | 3,158 | 2,734 | 0 |
| TOTAL | $14,075 | $14,857 | $15,924 | $16,111 | $N/A |
| Total Assets | $51,271 | $58,011 | $75,268 | $74,228 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 792 | 583 | 4,438 | 2,563 | 0 |
| Accrued Expenses | 8,791 | 7,961 | 12,288 | 9,264 | N/A |
| TOTAL | $9,583 | $8,544 | $16,726 | $11,827 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,465 | 18,586 | 18,895 | N/A | N/A |
| Other Non-Current Liabilities | 14,202 | 15,414 | 15,319 | 33,438 | -169 |
| TOTAL | $32,667 | $34,000 | $34,377 | $33,607 | $N/A |
| Total Liabilities | $42,250 | $42,544 | $51,103 | $45,434 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 1 | 1 | 1 | 1 | N/A |
| Retained earnings | -677,310 | -670,345 | -660,817 | -655,667 | N/A |
| Other shareholders' equity | -3,043 | -708 | -804 | -1,223 | 0 |
| TOTAL | $9,021 | $15,467 | $24,165 | $28,794 | $N/A |
| Total Liabilities And Equity | $51,271 | $58,011 | $75,268 | $74,228 | $0 |